RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Laboratorio Reig Jofre Stock

Laboratorio Reig Jofre EBIT 2024

Laboratorio Reig Jofre EBIT

14.44 M EUR

Ticker

RJF.MC

ISIN

ES0165359029

WKN

A140EW

In 2024, Laboratorio Reig Jofre's EBIT was 14.44 M EUR, a 18.13% increase from the 12.23 M EUR EBIT recorded in the previous year.

The Laboratorio Reig Jofre EBIT history

YEAREBIT (undefined EUR)
2026e20.91
2025e17.93
2024e14.44
202312.23
20229.51
20219.3
20209.59
20196.57
20188.83
20179.02
20169.78
201511.75
20142.8
201315.6
20122
20110.1
2010-5.4
2009-7.7
2008-14.8
200713.4
200613.2
20054.8
20041.8

Laboratorio Reig Jofre Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Laboratorio Reig Jofre, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Laboratorio Reig Jofre from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Laboratorio Reig Jofre’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Laboratorio Reig Jofre. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Laboratorio Reig Jofre’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Laboratorio Reig Jofre’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Laboratorio Reig Jofre’s growth potential.

Laboratorio Reig Jofre Revenue, EBIT and net profit per share

DateLaboratorio Reig Jofre RevenueLaboratorio Reig Jofre EBITLaboratorio Reig Jofre Net Income
2026e404.69 M undefined20.91 M undefined18.19 M undefined
2025e377.68 M undefined17.93 M undefined15.77 M undefined
2024e350.29 M undefined14.44 M undefined13.22 M undefined
2023316.09 M undefined12.23 M undefined9.41 M undefined
2022271.15 M undefined9.51 M undefined8.11 M undefined
2021236.23 M undefined9.3 M undefined5.09 M undefined
2020230.08 M undefined9.59 M undefined5.67 M undefined
2019200.21 M undefined6.57 M undefined4.94 M undefined
2018180.47 M undefined8.83 M undefined9.27 M undefined
2017167.98 M undefined9.02 M undefined8.83 M undefined
2016161.13 M undefined9.78 M undefined7.68 M undefined
2015156.91 M undefined11.75 M undefined8.75 M undefined
201433.28 M undefined2.8 M undefined2.31 M undefined
2013121.7 M undefined15.6 M undefined9.5 M undefined
201231.4 M undefined2 M undefined1 M undefined
201129.9 M undefined100,000 undefined0 undefined
201029.5 M undefined-5.4 M undefined16.1 M undefined
200939 M undefined-7.7 M undefined-22.6 M undefined
2008135.5 M undefined-14.8 M undefined-44.9 M undefined
2007161.8 M undefined13.4 M undefined1.5 M undefined
2006154.1 M undefined13.2 M undefined3.8 M undefined
200594.5 M undefined4.8 M undefined4.6 M undefined
200449.4 M undefined1.8 M undefined3.8 M undefined

Laboratorio Reig Jofre stock margins

The Laboratorio Reig Jofre margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Laboratorio Reig Jofre. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Laboratorio Reig Jofre.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Laboratorio Reig Jofre's sales revenue. A higher gross margin percentage indicates that the Laboratorio Reig Jofre retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Laboratorio Reig Jofre's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Laboratorio Reig Jofre's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Laboratorio Reig Jofre's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Laboratorio Reig Jofre. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Laboratorio Reig Jofre's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Laboratorio Reig Jofre Margin History

Laboratorio Reig Jofre Gross marginLaboratorio Reig Jofre Profit marginLaboratorio Reig Jofre EBIT marginLaboratorio Reig Jofre Profit margin
2026e58.28 %5.17 %4.5 %
2025e58.28 %4.75 %4.17 %
2024e58.28 %4.12 %3.77 %
202358.28 %3.87 %2.98 %
202259.42 %3.51 %2.99 %
202162.81 %3.94 %2.16 %
202062.59 %4.17 %2.47 %
201965.89 %3.28 %2.47 %
201865.2 %4.89 %5.13 %
201764.08 %5.37 %5.26 %
201662.13 %6.07 %4.76 %
201562.31 %7.49 %5.58 %
201459.7 %8.4 %6.94 %
201361.96 %12.82 %7.81 %
201273.89 %6.37 %3.18 %
201173.58 %0.33 %0 %
201073.56 %-18.31 %54.58 %
200975.38 %-19.74 %-57.95 %
200850.92 %-10.92 %-33.14 %
200759.58 %8.28 %0.93 %
200659.31 %8.57 %2.47 %
200550.69 %5.08 %4.87 %
200447.17 %3.64 %7.69 %

Laboratorio Reig Jofre Aktienanalyse

What does Laboratorio Reig Jofre do?

Laboratorio Reig Jofre SA is a leading company in the pharmaceutical industry, specializing in the development, manufacturing, and marketing of drugs. The company was founded in 1929 by the Reig Jofre brothers in Barcelona, Spain. It has since become an international company with a wide portfolio of products and a high level of innovation and quality. The business model of Laboratorio Reig Jofre SA is based on implementing research and innovation in the field of pharmacy. The company has its own R&D department, which collaborates closely with major scientific organizations and universities in Spain to understand and apply the latest developments and innovations in the industry. Laboratorio Reig Jofre SA has three main divisions - human pharmaceuticals, veterinary medicine, and chemical products used in various industries such as cosmetics and food. The human pharmaceutical division includes a variety of products, including prescription drugs, over-the-counter products, and generics, with a focus on therapy areas such as oncology, antibiotics, gynecology, and central nervous system disorders. The veterinary medicine division provides a wide range of vaccines and medications for animal health. The third division of chemical products includes various products such as emulsifiers, preservatives, and natural dyes that can be used in different industries. Some of the most well-known products of Laboratorio Reig Jofre SA include the antibiotic Nitrofurantoin, the analgesic Algiasdin, the hormonal preparation Ovusitol, and the vaccine against Bluetongue in animals. The company has also carried out several successful acquisitions to expand its portfolio and strengthen its international presence. The acquisition of Derivados Quimicos SA (Derma SA) introduced Laboratorio Reig Jofre SA to the skincare sector and strengthened its presence in Latin America. The acquisition of Bioiberica SA introduced the company to the field of bioactive molecules and chondroprotectants. Laboratorio Reig Jofre SA is a company that places quality and innovation at the heart of its activities. The company has a strong corporate culture based on respect, transparency, integrity, and commitment. It has also shown a strong commitment to sustainability and social responsibility, with initiatives such as supporting projects to improve the health of women and children in Africa and implementing environmentally friendly practices in production. Overall, Laboratorio Reig Jofre SA is a leading company in the pharmaceutical industry, capable of offering a wide range of products through research, innovation, and quality. With its diverse portfolio of products and its commitment to sustainability and social responsibility, the company is well-equipped to continue playing a leading role in the industry in the future. Laboratorio Reig Jofre ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Laboratorio Reig Jofre's EBIT

Laboratorio Reig Jofre's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Laboratorio Reig Jofre's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Laboratorio Reig Jofre's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Laboratorio Reig Jofre’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Laboratorio Reig Jofre stock

How much did Laboratorio Reig Jofre achieve in EBIT for the current year?

In the current year, Laboratorio Reig Jofre has achieved an EBIT of 14.44 M EUR.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Laboratorio Reig Jofre.

How has the EBIT of Laboratorio Reig Jofre developed in recent years?

The EBIT of Laboratorio Reig Jofre has increased by 18.133% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Laboratorio Reig Jofre?

The EBIT of Laboratorio Reig Jofre is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Laboratorio Reig Jofre pay?

Over the past 12 months, Laboratorio Reig Jofre paid a dividend of 0.08 EUR . This corresponds to a dividend yield of about 2.76 %. For the coming 12 months, Laboratorio Reig Jofre is expected to pay a dividend of 0.06 EUR.

What is the dividend yield of Laboratorio Reig Jofre?

The current dividend yield of Laboratorio Reig Jofre is 2.76 %.

When does Laboratorio Reig Jofre pay dividends?

Laboratorio Reig Jofre pays a quarterly dividend. This is distributed in the months of July, August, June, June.

How secure is the dividend of Laboratorio Reig Jofre?

Laboratorio Reig Jofre paid dividends every year for the past 10 years.

What is the dividend of Laboratorio Reig Jofre?

For the upcoming 12 months, dividends amounting to 0.06 EUR are expected. This corresponds to a dividend yield of 2.18 %.

In which sector is Laboratorio Reig Jofre located?

Laboratorio Reig Jofre is assigned to the 'Health' sector.

Wann musste ich die Aktien von Laboratorio Reig Jofre kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Laboratorio Reig Jofre from 6/21/2024 amounting to 0.04 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Laboratorio Reig Jofre pay the last dividend?

The last dividend was paid out on 6/21/2024.

What was the dividend of Laboratorio Reig Jofre in the year 2023?

In the year 2023, Laboratorio Reig Jofre distributed 0.996 EUR as dividends.

In which currency does Laboratorio Reig Jofre pay out the dividend?

The dividends of Laboratorio Reig Jofre are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Laboratorio Reig Jofre

Our stock analysis for Laboratorio Reig Jofre Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratorio Reig Jofre Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.